US 6129914
Bispecific antibody effective to treat B-cell lymphoma and cell line
expired A61KA61K2039/505A61K38/00
Quick answer
US patent 6129914 (Bispecific antibody effective to treat B-cell lymphoma and cell line) held by Protein Design Labs, Inc. expires Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Protein Design Labs, Inc.
- Grant date
- Tue Oct 10 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P35/00